Additionally, while the MYC family of oncogenes regulates the expression of DHODH, the key enzymes in de novo pyrimidine synthesis, DHODH inhibitors downregulate c-MYC in melanoma, myeloma, and lymphoma cells. This evidence concerns the gene DHODH and plasma cell myeloma.